CD19 and congenital rubella syndrome: Neurotoxicity has also been observed concurrent with or following CRS in some patients treated with CD19 CAR T cells, the cause of which is not clear although there are reports that CD19 CAR‐T cells may penetrate the blood‐brain barrier and attack cells expressing CD19.2, 3, 4, 5, 7